Insulin receptor substrate 2 (IRS2) confers resistance to PI3K pathway inhibition in PIK3CA mutant breast cancer.
- DOI
- 10.1016/j.jbc.2026.113426
- Published
- 2026 Aug 10
- Container
- The Journal of biological chemistry
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jbc.2026.113426,
title = {Insulin receptor substrate 2 (IRS2) confers resistance to PI3K pathway inhibition in PIK3CA mutant breast cancer.},
author = {Lero MW and Morgan JS and Card MA and Zhu LJ and Li J and Li R and Bui QT and Mohlmann E and Goel HL and Shaw LM},
year = {2026},
journal = {The Journal of biological chemistry},
doi = {10.1016/j.jbc.2026.113426},
url = {https://doi.org/10.1016/j.jbc.2026.113426}
}RIS
TY - JOUR TI - Insulin receptor substrate 2 (IRS2) confers resistance to PI3K pathway inhibition in PIK3CA mutant breast cancer. AU - Lero MW AU - Morgan JS AU - Card MA AU - Zhu LJ AU - Li J AU - Li R AU - Bui QT AU - Mohlmann E AU - Goel HL AU - Shaw LM PY - 2026 JO - The Journal of biological chemistry DO - 10.1016/j.jbc.2026.113426 UR - https://doi.org/10.1016/j.jbc.2026.113426 ER -
APA
MW, L., JS, M., MA, C., LJ, Z., J, L., R, L., QT, B., E, M., HL, G., & LM, S. (2026). Insulin receptor substrate 2 (IRS2) confers resistance to PI3K pathway inhibition in PIK3CA mutant breast cancer.. The Journal of biological chemistry. https://doi.org/10.1016/j.jbc.2026.113426
Source records
- pubmed · retrieved 2026-09-25T10:51:32.397Z
- europe-pmc · retrieved 2026-09-25T10:51:32.386Z